Clinical Trial Update: Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous bone marrow-derived mesenchymal stromal cell transplantation for Kienböck's disease; the study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kienböck Disease

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stromal cell transplantation (bone marrow-derived mesenchymal stromal cells (BM-MSCs))

Snippet

Sponsor: Royan Institute | Conditions: Kienböck's Disease | Phase 1 | Status: UNKNOWN